The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia
Abstract
The genes for the succinate dehydrogenase (SDH) subunits SDHA, SDHB, SDHC and SDHD are encoded in the autosome. The proteins are assembled in the mitochondria to form the mitochondrial complex 2, a key respiratory enzyme which links the Krebs cycle and the electron transport chain. Thirty percent of phaeochromocytoma and paraganglioma (PHEO/PGL) are hereditary and perhaps as many as half of these familial cases are caused by germline mutations of the SDH subunits. Negative immunohistochemical staining for the SDHB subunit identifies PHEO/PGL associated with germline mutation of any of the mitochondrial complex 2 components and can be used to triage formal genetic testing of all PHEO/PGL for SDH mutations. PHEO/PGL associated with SDHA mutation also show negative staining for SDHA as well as SDHB.A unique subgroup of gastrointestinal stromal tumours (GISTs) are driven by mitochondrial complex 2 dysfunction. These SDH deficient GISTs can also be definitively identified by negative staining for SDHB and show distinct clinical and morphological features including frequent onset in childhood and young adulthood, gastric location, a tendency to multifocality, absence of KIT and PDGFRA mutations, a prognosis not predicted by size and mitotic rate and a tendency to indolent behaviour of metastases. Some of these SDH deficient GISTs are driven by classical SDH mutations, but the precise mechanisms of tumourigenesis in many (including those associated with the Carney triad) remain unknown. Germline SDHB mutation is associated with a newly recognised type of renal carcinoma which commonly but not always demonstrates distinctive morphology and can also be recognised by negative staining for SDHB.Immunohistochemistry for SDHB therefore has emerged as a useful tool to recognise these distinct neoplasias driven by mitochondrial complex 2 dysfunction and to triage formal genetic testing for the associated syndromes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Germ-line mutations in all Sdh subunit genes can cause mitochondrial disease and tumor susceptibility syndromes (Gill, 2012).”
From SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways (2013) · cites this paper as Gill, 2012
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,350
Targeting metabolic transformation for cancer therapy
Tennant, D. A., Durán, R. V., & Gottlieb, E. (2010) · Nature reviews. Cancer · doi:10.1038/nrc2817 · Cited by 1,073
SDH5 , a Gene Required for Flavination of Succinate Dehydrogenase, Is Mutated in Paraganglioma
Hao, H.-X., Khalimonchuk, O., Schraders, M., Dephoure, N., Bayley, J.-P., Kunst, H., Devilee, P., Cremers, C. W. R. J., Schiffman, J. D., Bentz, B. G., et al. (2009) · Science · doi:10.1126/science.1175689 · Cited by 702 · cited 4×
“It was only after these first reports that germline mutation of SDHAF2 (previously called SDH5) and SDHA were shown to be associated with PHEO/PGL.(18,19) The PHEO/PGL associated with these mutations have now been shown to also demonstrate negative staining for SDHB.”
BackgroundInfluentialSDHA is a tumor suppressor gene causing paraganglioma
Burnichon, N., Brière, J.-J., Libé, R., Vescovo, L., Rivière, J., Tissier, F., Jouanno, E., Jeunemaı̂tre, X., Bénit, P., Tzagoloff, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq206 · Cited by 645
Janeway, K. A., Kim, S. Y., Lodish, M., Nosé, V., Rustin, P., Gaal, J., Dahia, P. L. M., Liegl, B., Ball, E. R., Raygada, M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009199108 · Cited by 628
van Nederveen, F. H., Gaal, J., Favier, J., Korpershoek, E., Oldenburg, R. A., de Bruyn, E. M., Sleddens, H. F. B. M., Derkx, P., Rivière, J., Dannenberg, H., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70164-0 · Cited by 554
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
Comino‐Méndez, I., Gracia-Aznárez, F. J., Schiavi, F., Landa, I., Leandro-Garcia, L. J., Letón, R., Honrado, E., Ramos‐Medina, R., Caronia, D., Pita, G., et al. (2011) · Nature Genetics · doi:10.1038/ng.861 · Cited by 528
Succinate Dehydrogenase-Deficient GISTs
Miettinen, M., Wang, Z.-F., Sarlomo‐Rikala, M., Osuch, C., Rutkowski, P. L., & Lasota, J. P. (2011) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182260752 · Cited by 361
Research works printed but not linked: 2
- Burnichon, 2010, SDHA is a tumor suppressor gene causing paraganglioma, Hum Mol Genet, 19, 3011, 10.1093/hmg/ddq206 · DOI
- Walter, 2012, How immunohistochemistry can help to identify renal tumors associated with SDHB syndrome, Mod Pathol, 249A, 1046
Cited by
Sorted by citations
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
Srigley, J. R., Delahunt, B., Eble, J. N., Egevad, L., Epstein, J. I., Grignon, D. J., Hes, O., Moch, H., Montironi, R., Tickoo, S. K., et al. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318299f2d1 · Cited by 1,050
SIRT5-mediated lysine desuccinylation impacts diverse metabolic pathways
Park, J., Chen, Y., Tishkoff, D. X., Peng, C., Tan, M., Dai, L., Xie, Z., Zhang, Y., Zwaans, B. M. M., Skinner, M. E., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.06.001 · Cited by 1,000
Succinate Dehydrogenase (SDH)-deficient Renal Carcinoma
Gill, A. J., Hes, O., Papathomas, T. G., Šedivcová, M., Tan, P. H., Agaimy, A., Andresen, P. A., Kedziora, A., Clarkson, A., Toon, C. W., et al. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000292 · Cited by 348
Self-citationGastrointestinal Stromal Tumors
von Mehren, M., & Joensuu, H. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.9705 · Cited by 314
Mitochondrial complex ii: At the crossroads
Bezawork-Geleta, A., Rohlena, J., Dong, L., Pacak, K., & Neuzil, J. (2017) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2017.01.003 · Cited by 295
Trpkov, K., Hes, O., Williamson, S. R., Adeniran, A., Agaimy, A., Alaghehbandan, R., Amin, M. B., Argani, P., Chen, Y., Liang Cheng, C., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00779-w · Cited by 275
Self-citationSuccinate dehydrogenase (SDH)‐deficient neoplasia
Gill, A. J. (2017) · Histopathology · doi:10.1111/his.13277 · Cited by 263
Self-citationWilliamson, S. R., Eble, J. N., Amin, M. B., Gupta, N., Smith, S. C., Sholl, L. M., Montironi, R., Hirsch, M. S., & Hornick, J. L. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.86 · Cited by 226
Recurrent epimutation of SDHC in gastrointestinal stromal tumors
Killian, J. K., Miettinen, M., Walker, R. L., Wang, Y., Zhu, Y. J., Waterfall, J. J., Noyes, N., Retnakumar, P., Yang, Z., Smith, W. I., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009961 · Cited by 194
Hall, A., Meyle, K. D., Lange, M. K., Klima, M., Sanderhoff, M., Dahl, C., Abildgaard, C., Thorup, K., Moghimi, S. M., Jensen, P. B., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.965 · Cited by 191
Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) – A review
Miettinen, M., & Lasota, J. P. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.05.033 · Cited by 168
Inamura, K. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102195 · Cited by 164
Pathology and genetics of phaeochromocytoma and paraganglioma
Turchini, J., Cheung, V. K.-Y., Tischler, A. S., de Krijger, R. R., & Gill, A. J. (2017) · Histopathology · doi:10.1111/his.13402 · Cited by 148
Self-citationPapathomas, T. G., Gaal, J., Corssmit, E. P. M., Oudijk, L., Korpershoek, E., Heimdal, K., Bayley, J., Morreau, H., van Dooren, M., Papaspyrou, K., et al. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0623 · Cited by 146
Fumarate Hydratase–deficient Uterine Leiomyomas Occur in Both the Syndromic and Sporadic Settings
Harrison, W. J., Andrici, J., Maclean, F. M., Ghahan, R. M., Farzin, M., Sioson, L., Toon, C. W., Clarkson, A., Watson, N., Pickett, J., et al. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000573 · Cited by 151
Self-citationNew and emerging renal entities: a perspective post‐ WHO 2016 classification
Trpkov, K., & Hes, O. (2018) · Histopathology · doi:10.1111/his.13727 · Cited by 147
Loss of expression of SDHA predicts SDHA mutations in gastrointestinal stromal tumors
Wagner, A. J., Remillard, S. P., Zhang, Y., Doyle, L. A., George, S., & Hornick, J. L. (2012) · Modern Pathology · doi:10.1038/modpathol.2012.153 · Cited by 139
The role of complex II in disease
Hoekstra, A. S., & Bayley, J. (2012) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2012.11.005 · Cited by 145
Szűcs, Z., Thway, K., Fisher, C., Bulusu, R., Constantinidou, A., Benson, C., van der Graaf, W. T. A., & Jones, R. L. (2016) · Future Oncology · doi:10.2217/fon-2016-0192 · Cited by 134
Re‐evaluation of 33 ‘unclassified’ eosinophilic renal cell carcinomas in young patients
Li, Y., Reuter, V. E., Matoso, A., Netto, G. J., Epstein, J. I., & Argani, P. (2017) · Histopathology · doi:10.1111/his.13395 · Cited by 136
IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma
Zhang, C., Moore, L. M., Li, X., Yung, W. K. A., & Zhang, W. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not087 · Cited by 136
Hsieh, J. J.-D., Le, V., Cao, D., Cheng, E. H. Y., & Creighton, C. J. (2017) · The Journal of Pathology · doi:10.1002/path.5022 · Cited by 131
SDHB-Deficient Cancers: The Role of Mutations That Impair Iron Sulfur Cluster Delivery
Saxena, N., Maio, N., Crooks, D. R., Ricketts, C. J., Yang, Y., Wei, M.-H., Fan, T. W. ‐., Lane, A. N., Sourbier, C., Singh, A., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv287 · Cited by 125
Dwight, T., Benn, D. E., Clarkson, A., Vilain, R. E., Lipton, L. R., Robinson, B. G., Clifton-Bligh, R. J., & Gill, A. J. (2012) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3182671155 · Cited by 118
Self-citationIron: An Essential Element of Cancer Metabolism
Hsu, M. Y., Mina, E., Roetto, A., & Porporato, P. E. (2020) · Cells · doi:10.3390/cells9122591 · Cited by 119
Succinate in the cancer–immune cycle
Jiang, S., & Yan, W. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.01.019 · Cited by 111
Williamson, S. R., Gill, A. J., Argani, P., Chen, Y., Egevad, L., Kristiansen, G., Grignon, D. J., & Hes, O. (2020) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001476 · Cited by 112
Self-citationFumarase-deficient Uterine Leiomyomas
Miettinen, M., Felisiak-Gołąbek, A., Wasąg, B., Chmara, M., Wang, Z., Bützow, R. C., & Lasota, J. P. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000703 · Cited by 99
Metabolic alterations in renal cell carcinoma
Massari, F., Ciccarese, C., Santoni, M., Brunelli, M., Piva, F., Modena, A., Bimbatti, D., Fantinel, E., Santini, D., Liang Cheng, C., et al. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.07.002 · Cited by 99
Ginsenoside Rb1 and mitochondria: A short review of the literature
Zhou, P., Xie, W., Sun, Y., Dai, Z., Li, G., Sun, G., & Sun, X. (2018) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2018.12.001 · Cited by 87
Succinate Dehydrogenase Deficiency Is Rare in Pituitary Adenomas
Gill, A. J., Toon, C. W., Clarkson, A., Sioson, L., Chou, A. S. Y., Winship, I., Robinson, B. G., Benn, D. E., Clifton-Bligh, R. J., & Dwight, T. (2014) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000149 · Cited by 86
Self-citationNiemeijer, N. D., Papathomas, T. G., Korpershoek, E., de Krijger, R. R., Oudijk, L., Morreau, H., Bayley, J., Hes, F. J., Jansen, J. C., Dinjens, W. N. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2689 · Cited by 81
Zhang, W., & Lang, R. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1266973 · Cited by 88
Update on Molecular Genetics of Gastrointestinal Stromal Tumors
Brčić, I., Argyropoulos, A., & Liegl‐Atzwanger, B. (2021) · Diagnostics · doi:10.3390/diagnostics11020194 · Cited by 74
Elston, M. S., Meyer-Rochow, G. Y., Conaglen, H. M., Clarkson, A., Clifton-Bligh, R. J., Conaglen, J. V., & Gill, A. J. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.11.012 · Cited by 72
Self-citationOverview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes
Nosé, V., Gill, A. J., Cameselle‐Teijeiro, J., Perren, A. A., & Erickson, L. A. (2022) · Endocrine Pathology · doi:10.1007/s12022-022-09705-5 · Cited by 70
Self-citationA Novel SDHA-deficient Renal Cell Carcinoma Revealed by Comprehensive Genomic Profiling
Yakirevich, E., Ali, S. M., Mega, A. E., McMahon, C., Brodsky, A. S., Ross, J. S., Allen, J. M., Elvin, J. A., Safran, H. P., & Resnick, M. B. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000403 · Cited by 68
Challenges in Paragangliomas and Pheochromocytomas: from Histology to Molecular Immunohistochemistry
Juhlin, C. C. (2021) · Endocrine Pathology · doi:10.1007/s12022-021-09675-0 · Cited by 69
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification
Rizzo, M., Caliò, A., Brunelli, M., Pezzicoli, G., Ganini, C., Martignoni, G., & Porta, C. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102558 · Cited by 70
Gastrointestinal stromal tumor: Recent advances in pathology and genetics
Yamamoto, H., & Oda, Y. (2014) · Pathology International · doi:10.1111/pin.12230 · Cited by 58
MacFarlane, J., Seong, K. C., Bisambar, C., Madhu, B., Allinson, K. S. J., Marker, A. J., Warren, A. Y., Park, S., Giger, O., Challis, B., et al. (2020) · Clinical Endocrinology · doi:10.1111/cen.14289 · Cited by 64
Jiang, M., Wang, C., Zhang, Y., Feng, Y., Wang, Y., & Zhu, Y. (2013) · Phytochemical Analysis · doi:10.1002/pca.2461 · Cited by 58
Gastrointestinal Stromal Tumors
Barnett, C. M., Corless, C. L., & Heinrich, M. C. (2013) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2013.07.003 · Cited by 57
Fuchs, T. L., Maclean, F. M., Turchini, J., Vargas, A. C., Bhattarai, S., Agaimy, A., Hartmann, A., Kao, C., Ellis, C. L., Bonert, M., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00998-1 · Cited by 55
Self-citationYang, X., Wang, H., Huang, C. S., He, X., Xu, W., Luo, Y., & Huang, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-14868-x · Cited by 53
Carney Triad, Carney-Stratakis Syndrome, 3PAS and Other Tumors Due to SDH Deficiency
Pitsava, G., Settas, N., Faucz, F. R., & Stratakis, C. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.680609 · Cited by 58
Succinate dehydrogenase-deficient gastrointestinal stromal tumors
Wang, Y. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i8.2303 · Cited by 55
Germline SDHC mutation presenting as recurrent SDH deficient GIST and renal carcinoma
Gill, A. J., Lipton, L. R., Taylor, J., Benn, D. E., Richardson, A. L., Frydenberg, M., Shapiro, J., Clifton-Bligh, R. J., Chow, C. W., & Bogwitz, M. R. (2013) · Pathology · doi:10.1097/pat.0000000000000018 · Cited by 54
Self-citationClassification of gastrointestinal stromal tumor syndromes
Gopie, P., Mei, L., Faber, A. C., Grossman, S. R., Smith, S. C., & Boikos, S. A. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0329 · Cited by 54
Molecular characterization and pathogenesis of gastrointestinal stromal tumor
Niinuma, T., Suzuki, H., & Sugai, T. (2018) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2018.01.02 · Cited by 55
Özlük, Y., Taheri, D., Matoso, A., Şanlı, Ö., Berker, N. K., Yakirevich, E., Balasubramanian, S., Ross, J. S., Ali, S. M., & Netto, G. J. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.07.027 · Cited by 51
Koopman, K., Gaal, J., & de Krijger, R. R. (2019) · Cancers · doi:10.3390/cancers11081070 · Cited by 55
Genotyping and immunohistochemistry of gastrointestinal stromal tumors: An update
Rubin, B. P., & Heinrich, M. C. (2015) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2015.02.017 · Cited by 50
The Adrenal Medulla and Extra-adrenal Paraganglia: Then and Now
Tischler, A. S., Pacák, K., & Eisenhofer, G. (2013) · Endocrine Pathology · doi:10.1007/s12022-013-9286-3 · Cited by 49
Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine
Bhutia, Y. D., Babu, E., & Ganapathy, V. (2016) · Biochemical Journal · doi:10.1042/bcj20160068 · Cited by 49
Sousa, S. M. C. D., McCabe, M. J., Wu, K. H. C., Roscioli, T., Gayevskiy, V., Brook, K., Rawlings, L. H., Scott, H. S., Thompson, T. J., Earls, P., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-16-0944 · Cited by 46
Self-citationNext generation immunohistochemistry: Emerging substitutes to genetic testing?
Andrici, J., Gill, A. J., & Hornick, J. L. (2017) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2017.05.004 · Cited by 44
Self-citationWallace, P. W., Conrad, C., Brückmann, S., Pang, Y. K., Caleiras, E. J., Murakami, M., Korpershoek, E., Zhuang, Z., Rapizzi, E., Kroiß, M., et al. (2020) · The Journal of Pathology · doi:10.1002/path.5472 · Cited by 43
Self-citationThe phenotype of SDHB germline mutation carriers: a nationwide study
Niemeijer, N. D., Rijken, J. A., Eijkelenkamp, K., van der Horst‐Schrivers, A. N. A., Kerstens, M. N., Tops, C. M. J., van Berkel, A., Timmers, H. J. L. M., Kunst, H. P. M., Leemans, C. R., et al. (2017) · European Journal of Endocrinology · doi:10.1530/eje-17-0074 · Cited by 43
Tsang, V., Dwight, T., Benn, D. E., Meyer-Rochow, G. Y., Gill, A. J., Sywak, M. S., Sidhu, S., Veivers, D., Sue, C. M., Robinson, B. G., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0519 · Cited by 42
Self-citationAghamir, S. M. K., Heshmat, R., Ebrahimi, M., Ketabchi, S. E., Parichehreh-Dizaji, S., & Khatami, F. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s207460 · Cited by 39
Powerhouse down: Complex II dissociation in the respiratory chain
Hwang, M., Rohlena, J., Dong, L., Neužil, J., & Grimm, S. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.06.001 · Cited by 39
Succinate Dehydrogenase–Deficient Renal Cell Carcinoma
Tsai, T.-H., & Lee, W. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2018-0024-rs · Cited by 39
Jiang, Q., Zhang, Y., Zhou, Y., Hou, Y., Wang, J., Li, J., Li, M., Tong, H., & Lu, W. (2015) · PubMed Central · Cited by 38
Succinate Dehydrogenase–Deficient Renal Cell Carcinoma: A Short Review
Wang, G., & Rao, P. (2018) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2017-0199-rs · Cited by 38
Oudijk, L., Gaal, J., & de Krijger, R. R. (2018) · Endocrine Pathology · doi:10.1007/s12022-018-9555-2 · Cited by 37
Molecular Genetics of Renal Cell Tumors: A Practical Diagnostic Approach
Alaghehbandan, R., Pérez‐Montiel, D., Luís, A. S., & Hes, O. (2019) · Cancers · doi:10.3390/cancers12010085 · Cited by 35
Utility of the succinate:fumarate ratio for assessing SDH dysfunction in different tumor types
Kim, E., Wright, M. J., Sioson, L., Novos, T., Gill, A. J., Benn, D. E., White, C., Dwight, T., & Clifton-Bligh, R. J. (2016) · Molecular Genetics and Metabolism Reports · doi:10.1016/j.ymgmr.2016.12.006 · Cited by 38
Self-citationdos Santos, P. L., Pimenta, T., & Taveira‐Gomes, A. (2014) · International Journal of Surgical Pathology · doi:10.1177/1066896914537683 · Cited by 35
Paik, J. Y., Toon, C. W., Benn, D. E., High, H. A., Hasovitz, C., Pavlakis, N., Clifton-Bligh, R. J., & Gill, A. J. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.2647 · Cited by 34
Self-citationFlynn, A., Dwight, T., Harris, J., Benn, D. E., Zhou, L., Hogg, A., Catchpoole, D. R., James, P. A., Duncan, E. L., Trainer, A. H., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3889 · Cited by 34
Self-citationMaklashina, E., Rajagukguk, S., Iverson, T. M., & Cecchini, G. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.001977 · Cited by 30
Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma
Cornejo, K. M., Lu, M., Yang, P., Wu, S., Cai, C., Zhong, W., Olumi, A. F., Young, R. H., & Wu, C. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.02.013 · Cited by 30
The Effect of CoQ10 supplementation on ART treatment and oocyte quality in older women
Brown, A. M., & McCarthy, H. E. (2023) · Human Fertility · doi:10.1080/14647273.2023.2194554 · Cited by 31
Update on paragangliomas and pheochromocytomas
Lam, A. K.-Y. (2015) · Turkish Journal of Pathology · doi:10.5146/tjpath.2015.01318 · Cited by 28
Tumorigenesis Mechanisms Found in Hereditary Renal Cell Carcinoma: A Review
Webster, B. R., Gopal, N., & Ball, M. W. (2022) · Genes · doi:10.3390/genes13112122 · Cited by 28
Song, L., Xue, J., Xu, L., Cheng, L., Zhang, Y., & Wang, X. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112468 · Cited by 28
Lee, C., Gundem, G., Lee, W., Chen, Y., Cross, J. R., Dong, Y., Redzematovic, A., Mano, R., Wei, E. Y., Cheng, E. H. Y., et al. (2017) · JCO Precision Oncology · doi:10.1200/po.16.00007 · Cited by 24
Newly Available Antibodies With Practical Applications in Surgical Pathology
Chan, J. K. C. (2013) · International Journal of Surgical Pathology · doi:10.1177/1066896913507601 · Cited by 23
Research progress on the pathogenesis of the SDHB mutation and related diseases
Liu, C., Zhou, D., Yang, K., Xu, N., Peng, J., & Zhu, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115500 · Cited by 23
Genetically Modeled Mice with Mutations in Mitochondrial Metabolic Enzymes for the Study of Cancer
Piruat, J. I., & Millán‐Uclés, Á. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00200 · Cited by 21
Ishii, M., Akaike, K., Suehara, Y., Mukaihara, K., Kubota, D., Kohsaka, S., Okubo, T., Mitani, K., Mogushi, K., Takagi, T., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.138 · Cited by 22
An exploration in pitfalls in interpreting SDHB immunohistochemistry
Ding, C. C., Chan, S. B., Mak, J. S., Umetsu, S. E., Simko, J., Ruiz‐Cordero, R., Saunders, T., & Chan, E. (2022) · Histopathology · doi:10.1111/his.14681 · Cited by 22
Fuchs, T. L., Luxford, C., Clarkson, A., Sheen, A., Sioson, L., Elston, M. S., CROXSON, M. S., Dwight, T., Benn, D. E., Tacon, L. J., et al. (2022) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001945 · Cited by 22
Self-citationA Duodenal SDH-Deficient Gastrointestinal Stromal Tumor in a Patient With a Germline SDHB Mutation
Elston, M. S., Sehgal, S., Dray, M. S., Phillips, E., Conaglen, J. V., Clifton-Bligh, R. J., & Gill, A. J. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-00165 · Cited by 22
Self-citationTKI Treatment Sequencing in Advanced Gastrointestinal Stromal Tumors
Khosroyani, H. M., Klug, L. R., & Heinrich, M. C. (2023) · Drugs · doi:10.1007/s40265-022-01820-1 · Cited by 23
Fu, Y., Tao, L., Wang, X., Wang, B., Qin, W., & Song, L. (2024) · Experimental Gerontology · doi:10.1016/j.exger.2024.112428 · Cited by 21
Emerging Entities in Renal Neoplasia
Mehra, R., Smith, S. C., Divatia, M. K., & Amin, M. B. (2015) · Surgical pathology clinics · doi:10.1016/j.path.2015.08.004 · Cited by 21
Li, Q., Yang, Y., Wang, H. H., Jiang, Z., & Ma, H. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120676 · Cited by 21
Hereditary succinate dehydrogenase-deficient renal cell carcinoma
Rogala, J., & Zhou, M. (2023) · Seminars in Diagnostic Pathology · doi:10.1053/j.semdp.2023.11.001 · Cited by 20
Ranganayaki, S., Jamshidi, N., Aiyaz, M., Santhoshkumar, R., Gayathri, N., Harsha, P. K., Padmanabhan, B., & Bharath, M. M. S. (2021) · Scientific Reports · doi:10.1038/s41598-020-79339-2 · Cited by 20
Rao, Q., Xia, Q., Liang Cheng, C., & Zhou, X. (2016) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.1000-9604.2016.01.03 · Cited by 19
Turchini, J., & Gill, A. J. (2019) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001415 · Cited by 19
Self-citationMillán‐Uclés, Á., Castro, B. D., García‐Flores, P., Báez, A., Pérez‐Simón, J. A., López‐Barneo, J., & Piruat, J. I. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085528 · Cited by 19
Alterations of oxidative phosphorylation in meningiomas and peripheral nerve sheath tumors
Feichtinger, R. G., Weis, S., Mayr, J. A., Zimmermann, F., Bogner, B., Sperl, W., & Kofler, B. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov105 · Cited by 19
Gastrointestinal Stromal Tumor – An Evolving Concept
Tornillo, L. (2014) · Frontiers in Medicine · doi:10.3389/fmed.2014.00043 · Cited by 18
Molecular Genetics of Renal Cell Carcinoma: A Narrative Review Focused on Clinical Relevance
Millan, B., Loebach, L., Blachman-Braun, R., Patel, M. H., Saini, J., Linehan, W. M., & Ball, M. W. (2025) · Current Oncology · doi:10.3390/curroncol32060359 · Cited by 20
Succinate Dehydrogenase B (SDHB) Immunohistochemistry for the Evaluation of Muscle Biopsies
Punsoni, M., Mangray, S., Lombardo, K. A., Heath, N., Stopa, E. G., & Yakirevich, E. (2016) · Applied immunohistochemistry & molecular morphology · doi:10.1097/pai.0000000000000432 · Cited by 17
TUFM‑knockdown inhibits the migration and proliferation of gastrointestinal stromal tumor cells
Weng, X., Zheng, S., Shui, H., Lin, G., & Zhou, Y. (2020) · Oncology Letters · doi:10.3892/ol.2020.12113 · Cited by 16
Silva, M. D., Rastogi, S., Chan, D. L. H., Angel, C. M., Prall, O. W. J., Gill, A. J., & Guminski, A. D. (2021) · Translational Cancer Research · doi:10.21037/tcr-21-131 · Cited by 15
Self-citation
Metadata
- Authors
- Gill, A. J.
- Affiliations
- The University of Sydney (AU)
- Corresponding author
- Gill, Anthony J.
- ORCID
- Gill, Anthony J.
- Venue
- Pathology
- Publisher
- Elsevier BV
- Published
- 2012-06
- Volume
- 44
- Issue
- 4
- Pages
- 285-292
- ISSN
- 0031-3025 (ISSN-L)
- OpenAlex
- W2156718948
- Cited by
- 215
- References
- 46
- Citations by year
- 2026: 9 · 2025: 15 · 2024: 11 · 2023: 13 · 2022: 15 · 2021: 22 · 2020: 14 · 2019: 11 · 2018: 16 · 2017: 21 · 2016: 17 · 2015: 19 · 2014: 18 · 2013: 11 · 2012: 3
- FWCI
- 3.15
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Pathology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
- Keywords
- succinate dehydrogenase, SDHB, SDHA, SDHC, SDHD, pheochromocytoma, paraganglioma, gastrointestinal stromal tumor, renal carcinoma, Carney triad, germline mutations, immunohistochemistry, tumourigenesis, hereditary cancer
- MeSH terms
- Gastrointestinal Neoplasms, Genetic Testing, Humans, Membrane Proteins, Neoplasms, Neoplastic Syndromes, Hereditary, Paraganglioma, Pheochromocytoma, Succinate Dehydrogenase, Gene Expression Regulation, Neoplastic, Germ-Line Mutation, Genetic Predisposition to Disease, Protein Subunits, Mitochondrial Proteins, Gastrointestinal Stromal Tumors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
